Stephanie Lee, MD, MPH, Elected ASH Vice President; Two Councillors Appointed to 4-Year Terms


Get Permission

Stephanie Lee, MD, MPH

Stephanie Lee, MD, MPH

THE AMERICAN SOCIETY OF HEMATOLOGY (ASH) has elected Stephanie Lee, MD, MPH, a member of the Clinical Research Division at Fred Hutchinson Cancer Research Center (Fred Hutch), as its Vice President. Dr. Lee will begin her 1-year term after the 2017 ASH Annual Meeting & Exposition in December in Atlanta. It will be followed by successive 1-year terms as President-Elect and then as President. 

Dr. Lee is a transplant physician-scientist at Seattle Cancer Care Alliance, the clinical-care partner of Fred Hutch. She remarked that she plans to increase public appreciation and understanding of hematology research during her term as Vice President. 

Agnes Lee, MD

Agnes Lee, MD

Joseph Mikhael, MD

Joseph Mikhael, MD

Agnes Lee, MD, and Joseph Mikhael, MD, will each serve 4-year terms as Councillors. 

Dr. Agnes Lee is a Professor of Medicine at the University of British Columbia, Director of the Thrombosis Program at Vancouver Coastal Health and University of British Columbia, and Director of the Hematology Research Program at Vancouver General Hospital. Dr. Lee is currently a member of the Awards Committee, Small Meetings Oversight Subcommittee, and Guideline Panel on VTE in Patients with Cancer. 

Dr. Joseph Mikhael is Professor of Medicine at Mayo Clinic in Arizona, where he is also Deputy Director of the Mayo Clinic Cancer Center and Associate Dean at Mayo Clinic School of Graduate Medical Education. Dr. Mikhael currently serves on the steering committee of the CRTI program and chairs the ASH Committee on Communications. The councillors will begin their terms at the upcoming annual meeting being held in Atlanta. 

For more about the upcoming ASH Annual Meeting, be sure to watch future issues of The ASCO Post or visit The ASCO Post online at www. ASCOPost.com. ■


Advertisement

Advertisement



Advertisement